Dual Antiplatelet Therapy for Small Acute Ischemic Strokes (NINDS Score =5 and TIA)

Monday, August 2, 2021, 12:00 AM - Tuesday, August 2, 2022, 11:59 PM


AMA PRA Category 1 Credits™ (1.25 hours), AMA PRA Category 1 Credits™ Designated (1.25 hours)

This program covers strategies to prevent secondary stroke in patients who had an acute ischemic stroke or transient ischemic attack, as well as analyzes results of recent clinical trial data and application of agents used to manage small acute ischemic stroke.

1. Identify strategies to prevent secondary stroke in patients who had an acute ischemic stroke or transient ischemic attack.
2. Analyze the results of recently completed clinical trial data for P2Y12 agents in high risk, small acute ischemic stroke (NINDS Score =5 and TIA) patients.
3. Recall the clinical applications of P2Y12 agents and clinical trial results, and describe their application to clinical practice in the management of small acute ischemic stroke (NINDS Score =5 and TIA).
4. Discuss the Phase 3 trial using the oral agent for ischemic stroke or TIA plus aspirin vs. aspirin alone, and discussing the clinical application of the findings to improve outcomes.

This activity is FREE to all participants.

To access this program, please go to: https://www.mededonthego.com/Video/program/711 

Physician Continuing Medical Education:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati Office of Continuing Medical Education, EMCREG-International, and TotalCME, Inc. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Continuing Nurse Education:

Approved contact hours: 1.25 total continuing education contact hours for nurses are approved by the Ohio Board of Nursing through the OBN Approver Unit at the University of Cincinnati College of Nursing, Continuing Education Program (OBN-011-93). Contact hours are valid in most states. Program: 210715-2

Continuing Pharmacy Education:

The University of Cincinnati James L. Winkle College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0050-9999-21-041-H01-P. Activity type: Knowledge. This activity is worth a total of 1.25 CEUs (0.125 contact hours). Note: Pharmacists must complete all episodes in this activity to claim credit. Please contact the James L. Winkle College of Pharmacy Continuing Pharmacy Education Office at 513-558-4716 or [email protected] with questions or concerns.

The opinions expressed during this online activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

No faculty are available for this activity at this time.

This activity is supported in part by an independent educational grant from AstraZeneca Pharmaceuticals.